Short communication Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is characterized by recurrent clonal chromosomal abnormali- ties, with numerical abnormalities being a common feature especially among children. Case reports in the literature suggest that one such recurrent numerical abnormality is the gain of chromosome 5 (trisomy 5) as the sole abnormality; due to the rarity of these cases, however, little is known about their incidence, clinical features, and prognosis. We have identified seven cases with trisomy 5 as the sole or primary chromosomal abnormality from a total of 3,400 karyotypes collected in the Leukaemia Research Fund UK Cancer Cytogenetics Group Karyotype Database. All cases had a precursor B-cell immunophenotype and there was a male predominance. Five patients were children aged between 7 and 14 years old. Four of the six patients with a reasonable follow-up period had relapsed, indicating a poor prognosis. We conclude that trisomy 5 as the sole numerical abnormality occurs predominantly in older children, may be associated with a poor outcome, and may represent a distinct, albeit rare, cytogenetic subgroup in ALL. 2004 Elsevier Inc. All rights reserved.

[1]  M. Martineau,et al.  The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management , 2001, British journal of haematology.

[2]  S. Richards,et al.  Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol , 2001, British journal of haematology.

[3]  S. Richards,et al.  The Medical Research Council trials in adult acute lymphocytic leukemia. , 2000, Hematology/oncology clinics of North America.

[4]  P S Gaynon,et al.  Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Sandoval,et al.  Trisomy 5 as a sole cytogenetic abnormality in pediatric acute lymphoblastic leukemia. , 2000, Cancer genetics and cytogenetics.

[6]  A. Vora,et al.  Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials , 2000, Leukemia.

[7]  R. McNally,et al.  Age and sex distributions of hematological malignancies in the U.K. , 1997, Hematological oncology.

[8]  P. N. Rao,et al.  Trisomy 5 as the sole abnormality in acute lymphoblastic leukemia. A second case and review. , 1994, Cancer genetics and cytogenetics.

[9]  A. Look,et al.  Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. , 1992, Blood.

[10]  F. Behm,et al.  Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. , 1992, Leukemia.

[11]  J. Harbott,et al.  [Chromosome aberrations in acute leukemia in childhood: analysis of 1009 patients]. , 1991, Klinische Padiatrie.

[12]  M. Borowitz,et al.  Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A pediatric oncology group study , 1990, Cancer.

[13]  A. Sandberg,et al.  Trisomy 5 as sole anomaly in acute lymphoblastic leukemia. , 1988, Cancer genetics and cytogenetics.